Halozyme Therapeutics (HALO) Revenue (2010 - 2026)
Halozyme Therapeutics (HALO) reported Revenue of $481 million for Q2 2026, up 47.7% from $325.72 million a year earlier and up 27.7% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' Revenue came in at $1.66 billion, up 41.2% year-over-year; for FY2025, it was $1.4 billion, up 37.6% from FY2024.
- Revenue has increased for seven consecutive years, with a five-year compound annual growth rate of 39.2% (FY2020 to FY2025).
- By year, Revenue came in at $1.02 billion in FY2024 (+22.4%), $829.25 million in FY2023 (+25.6%), $660.12 million in FY2022 (+48.9%) and $443.31 million in FY2021 (+65.7%).
- The Q2 2026 figure ranks as the highest quarterly Revenue in data going back to Q2 2010.
- Year over year, Revenue has now increased in each of the last 18 quarters, with growth averaging 37.9% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q3 2022 (growth of 80.4%); the low point was Q4 2021 (a decline of 16.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $376.71 million (Q1 2026), $451.77 million (Q4 2025) and $354.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 481.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 481.00 Mn |
| Mar 31, 2026 | 376.71 Mn |
| Dec 31, 2025 | 451.77 Mn |
| Sep 30, 2025 | 354.26 Mn |
| Jun 30, 2025 | 325.72 Mn |
| Mar 31, 2025 | 264.86 Mn |
| Dec 31, 2024 | 298.01 Mn |
| Sep 30, 2024 | 290.08 Mn |
| Jun 30, 2024 | 231.35 Mn |
| Mar 31, 2024 | 195.88 Mn |
| Dec 31, 2023 | 230.04 Mn |
| Sep 30, 2023 | 216.03 Mn |
| Jun 30, 2023 | 221.04 Mn |
| Mar 31, 2023 | 162.14 Mn |
| Dec 31, 2022 | 181.50 Mn |
| Sep 30, 2022 | 208.98 Mn |
| Jun 30, 2022 | 152.37 Mn |
| Mar 31, 2022 | 117.28 Mn |
| Dec 31, 2021 | 102.00 Mn |
| Sep 30, 2021 | 115.83 Mn |
API Access
Halozyme Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();